Search results for " ESO"

Emergency sclerotherapy or band ligation combined with vasoactive drugs for bleeding esophageal varices in cirrhosis

2019

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy as well as adverse events of emergency sclerotherapy (or band ligation) combined with pharmacological treatments versus sclerotherapy (or band ligation) alone or vasoactive drugs alone for acute variceal bleeding in cirrhotic patients based on the results of randomised clinical trials (RCTs).

Immunohistochemical/histochemical double staining method in the study of the columnar metaplasia of the oesophagus

2014

Intestinal metaplasia in Barrett’s oesophagus (BO) represents an important risk factor for oesophageal adenocarcinoma. Instead, few and controversial data are reported about the progression risk of columnar-lined oesophagus without intestinal metaplasia (CLO), posing an issue about its clinical management. The aim was to evaluate if some immunophenotypic changes were present in CLO independently of the presence of the goblet cells. We studied a series of oesophageal biopsies from patients with endoscopic finding of columnar metaplasia, by performing some immunohistochemical stainings (CK7, p53, AuroraA) combined with histochemistry (Alcian-blue and Alcian/PAS), with the aim of simultaneousl…

Persistent and recurrent achalasia after Heller myotomy: analysis of different patterns and long-term results of reoperation.

2007

Hypothesis Two groups of patients with inadequate therapeutic success after surgical treatment for achalasia can be identified, patients with type 1 recurrence (early recurrence after technical failure of myotomy or a scarring process requiring remyotomy) and patients with type 2 recurrence (late recurrence with irreversible progression of the disease and development of megaesophagus requiring esophagectomy). Design Prospective study. Setting University-based tertiary care center. Patients One hundred sixty-three patients undergoing surgery for achalasia during 20.3 years. Interventions Conventional remyotomy for type 1 recurrence (group 1) and esophagectomy (transhiatal or transthoracic) f…

Extrathoracic Lengthening (Kimura Technique)

2021

Treatment of congenital long gap esophageal atresia is extremely challenging. Cases are rare, variable, and oftentimes complex. Possible treatment options include delayed primary repair after initial gastrostomy, gastric transposition, intestinal interpositions, traction procedures, myotomy, and gastric tube techniques. Treatment strategies often consist of variations and combinations of different approaches.

Zvaigžņotā Debess: 2018, Vasara (240)

2018

Jauna hipotēze par I tipa pārnovu izcelšanos ; No 108 minūtēm līdz 96 dienām ; Maiņzvaigznes (astronomija skolā) ; O.Dumbrājs. Nēteres teorēmai 100 gadu ; K.Švarcs. Jauni novērojumi tālā un tuvā kvazārā ; I.P. Īsumā: ALMA un VLT iegūst liecību par zvaigžņu veidošanos tikai 250 miljonus gadu pēc Lielā Sprādziena ; I.Pundure. Lagūnas miglājs – zvaigžņu bērnistaba Habla skatījumā ; I.Pundure. ALMA un APEX atklāj veidojošos galaktiku megasaplūšanu agrīnajā Visumā ; K.Salmiņš. LU Astronomijas institūts pirmais veicis nanopavadoņa S-NET lāzermērījumus ; J.Jaunbergs. Zeme atpakaļskata spogulī ; J.Jaunbergs. Sniegotā Helēne un mazais Polideiks ; R.Misa. Latvijas uzņēmums Eventech piedalīsies Luna-2…

Nanorings driven by strong laser fields: dynamics and applications

L'esodo dalla propria generazione

2015

Il testo sviluppa l'intuizione che, in primo luogo, la disposizione dei padri ad apprendere dai figli deve avere una parte essenziale e costitutiva nel lavoro educativo; e, in secondo luogo, che la testimonianza discreta, la verità umile dei padri, intercetta bene la domanda fortissima di paternità che c’è nei figli. I padri dunque hanno bisogno dei figli così come i figli hanno bisogno dei padri. Si può dire che ci troviamo di fronte ad un modo nuovo di concepire l’educazione? In effetti è un’idea nuova, alla quale forse non abbiamo mai, più di tanto, pensato: essa significa che l’educazione non può essere concepita come una trasmissione lineare, per così dire, dalle generazioni antecedent…

Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differ…

2012

The 1st St. Gallen EORTC Gastrointestinal Cancer Conference 2012 Expert Panel clearly differentiated treatment and staging recommendations for the various gastroesophageal cancers. For locally advanced gastric cancer (>= PT3N+), the preferred treatment modality was pre- and postoperative chemotherapy. The majority of panel members would also treat T2N+ or even T2N0 tumours with a similar approach mainly because pretherapeutic staging was considered highly unreliable. It was agreed that adenocarcinoma of the gastroesophageal junction (AEG) is classified best according to Siewert et al. Preoperative radiochemotherapy (RCT) is the preferred treatment for AEG type I and II tumours. For AEG type…

Sequential ipilimumab (Ipi) versus best supportive care (BSC) following first-line chemotherapy (Ctx) in patients (pts) with unresectable locally adv…

2013

TPS4151 Background: First-line systemic CTX is standard-of-care for advanced gastric cancer. However, most pts relapse or have severe adverse events (AEs), creating a need for new therapies with better benefit/risk and toxicity profiles. Endogenous immune activity against tumor cells has been demonstrated in the human gastric cancer tumor microenvironment, supporting a role for immunotherapy. As a new maintenance concept, sequential administration of immunotherapy may prolong clinical benefit of first-line CTX before disease progression (PD). Ipi, a fully human monoclonal antibody which binds CTLA-4, augments the antitumor immune response. Ipi improved overall survival (OS) in patients wit…

VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced es…

2014

Abstract Background Combination of fluoropyrimidines and a platinum derivative are currently standards for systemic chemotherapy in advanced adenocarcinoma of the stomach and gastroesophageal junction (GEJ). Nevertheless, individual likelihood for response to these therapeutic regimes remains uncertain. Even more, no predictive markers are available to determine which patients may benefit more from oxaliplatin versus cisplatin or vice versa. The new invasion and stem cell markers VEGFR-3 and CXCR4 have been linked prognostically with more aggressive esophagogastric cancer types. Thus, we aimed to assess correlations of VEGFR-3 and CXCR4 expression levels with clinical outcome in a randomize…